Biolife Sciences (Biolife Sciences) Common Stock : $0.04 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Common Stock?

Biolife Sciences's quarterly common stock increased from Nov. 2007 ($0.03 Mil) to Feb. 2008 ($0.03 Mil) and increased from Feb. 2008 ($0.03 Mil) to May. 2008 ($0.04 Mil).

Biolife Sciences's annual common stock increased from Nov. 2005 ($0.01 Mil) to Nov. 2006 ($0.01 Mil) and increased from Nov. 2006 ($0.01 Mil) to Nov. 2007 ($0.03 Mil).

Biolife Sciences Common Stock Historical Data

The historical data trend for Biolife Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Common Stock Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Common Stock

0.01

0.03

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Common Stock	Get a 7-Day Free Trial										0.02	0.02	0.03	0.03	0.04

Biolife Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020